PRAMODINI MEDICARE SHARE PRICE

Pramodini Medicare Limited was originally incorporated on September 12, 2000 as "Pramodini Medicare Private Limited" with the Registrar of Companies, Andhra Pradesh. Thereafter, the status of the Company changed to public limited Company and the name was changed to "Pramodini Medicare Limited" vide fresh certificate of incorporation dated November 12, 2025. Company was originally incorporated in the year 2000 with the objective to provide diagnostic services. The Company provide a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. Diagnostic services include a comprehensive range of offerings: (i) "Radiology" which covers Magnetic Resonance Imaging (MRI), Computed Tomography (CT scan), X- ray, Ultrasound with colour doppler, Mammography, DEXA Scan and Intervention Radiology, (ii) "Clinical Laboratory" which includes Haematology, Micro-Biology, Immunology, Pathology & Bio-Chemistry and (iii) "Nuclear Medicine" which includes PET-CT (Positron Emission Tomography-Computed Tomography), SPECT (Single Photon Emission Computed Tomography) and Nuclear therapy. The Company provide teleradiology services through its registered office situated at Vijayawada which functions on a 24x7 basis throughout the year. It provide healthcare services for core testing, patients diagnosis, disease prevention and monitoring of various health conditions. The services includes both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases. Apart from these, the business operates across four key models mainly the Public Private Partnership (with government hospitals and government teaching hospitals), Private Private Partnership (with private sector hospitals), Strategic Partnership with PSUs (Public Sector Undertakings) Government of India and Private Centres (standalone centre). The company has filed a Draft Prospectus with SEBI for the IPO by issuing the aggregate of 58,51,200 equity shares of Rs 10 each, which consist a fresh issue of 53,50,000 equity shares and the offer for sale of 5,00,400 equity shares.

Pramodini Medicare share price as on 21 Aug 2026 is Rs. 118. Over the past 6 months, the Pramodini Medicare share price has increased by 0% and in the last one year, it has decreased by 3%. The 52-week low for Pramodini Medicare share price was Rs. 114 and 52-week high was Rs. 125.55.

Pramodini Medicare Limited was originally incorporated on September 12, 2000 as "Pramodini Medicare Private Limited" with the Registrar of Companies, Andhra Pradesh. Thereafter, the status of the Company changed to public limited Company and the name was changed to "Pramodini Medicare Limited" vide fresh certificate of incorporation dated November 12, 2025. Company was originally incorporated in the year 2000 with the objective to provide diagnostic services. The Company provide a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. Diagnostic services include a comprehensive range of offerings: (i) "Radiology" which covers Magnetic Resonance Imaging (MRI), Computed Tomography (CT scan), X- ray, Ultrasound with colour doppler, Mammography, DEXA Scan and Intervention Radiology, (ii) "Clinical Laboratory" which includes Haematology, Micro-Biology, Immunology, Pathology & Bio-Chemistry and (iii) "Nuclear Medicine" which includes PET-CT (Positron Emission Tomography-Computed Tomography), SPECT (Single Photon Emission Computed Tomography) and Nuclear therapy. The Company provide teleradiology services through its registered office situated at Vijayawada which functions on a 24x7 basis throughout the year. It provide healthcare services for core testing, patients diagnosis, disease prevention and monitoring of various health conditions. The services includes both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases. Apart from these, the business operates across four key models mainly the Public Private Partnership (with government hospitals and government teaching hospitals), Private Private Partnership (with private sector hospitals), Strategic Partnership with PSUs (Public Sector Undertakings) Government of India and Private Centres (standalone centre). The company has filed a Draft Prospectus with SEBI for the IPO by issuing the aggregate of 58,51,200 equity shares of Rs 10 each, which consist a fresh issue of 53,50,000 equity shares and the offer for sale of 5,00,400 equity shares.

Pramodini Medicare share price as on 21 Aug 2026 is Rs. 118. Over the past 6 months, the Pramodini Medicare share price has increased by 0% and in the last one year, it has decreased by 3%. The 52-week low for Pramodini Medicare share price was Rs. 114 and 52-week high was Rs. 125.55.